Replies to post #744987 on NorthWest Biotherapeutics Inc (NWBO)

[StonkMaster]

I don't use AI often, but:

Northwest Biotherapeutics (NWBO) may have added these references to their patent to strengthen its claims and demonstrate scientific support for their approach. By including studies on CTLA-4 blockade and dendritic cell vaccines, they align their application with established research, showing a foundation for efficacy in combining therapies.

Theoretically, this addition could position NWBO for potential partnerships with companies developing CTLA-4 inhibitors, like Bristol-Myers Squibb, AstraZeneca, or BioNTech, as their technologies could complement each other. Partnerships often enhance development and market access for such combinations.

[WojD40]

Patent was filed in October of 2023, just before the MAA was filed and after a long summer of persistent rumours of combo deals.

[brooktrail1933]

I believe they have a partner. I believe it is not who everyone is speculating. As to who it is, look to personal relationships at the scientific levels.
All IMO.